NON-MEMBER | 2016 Annual Scientific Meeting (Non-CME)


General Information

The 20th Annual Scientific Meeting of the Heart Failure Society of America offers a diverse program including basic science, translational and clinical sessions. There is something for everyone interested in heart failure.

Target Audience

Sessions are designed to meet the range of needs from those new to heart failure to well-established specialist. Including:

  • Cardiologists, CV surgeons, Internists and Primary Care Physicians
  • Clinical researchers
  • Cardiac rehabilitation professionals
  • Nurses and Nurse Practitioners
  • Epidemiologists
  • Health Care Administrators
  • Industry
  • Pharmacists
  • Research Scientists

Standard: $450.00

Products

Clinical Fundamentals:  The Hemodynamics of HF

Preview Available

Clinical Fundamentals: The Hemodynamics of HF


  • Back to the Basics: Preload, Afterload, and Ventricular Function
  • Fundamental Hemodynamics in HFrEF and HFpEF
  • Diagnosis and Assessment of Pulmonary Hypertension
  • What is the Role of Provocative Testing – Drugs, Saline and Exercise?
  • Who Needs a Hemodynamic Cath in 2016?
  • Role of Implantable Hemodynamic Monitors
  • Panel Discussion

Moderator(s): Speaker(s): Moderator(s): Speaker(s):
  • Ryan Tedford, MD, Medical University of South Carolina
  • Barry A. Borlaug, MD, Mayo Clinic
  • James C. Fang, MD, FHFSA, Professor of Medicine; Chief, Division of Cardiovascular Medicine; Executive Director, Cardiovascular Service Line, University of Utah
  • Lynne Warner Stevenson, MD, Director of Cardiomyopathy, Lisa M Jacobson Professor of MedicineProfessor and Director of Cardiomyopathy & Program Director, Advanced Heart Failure Fellowship Program, Vanderbilt University

Plenary - Human iPS Cells: From Precision Medicine to Clinical Trial in a Dish

Preview Available

Plenary - Human iPS Cells: From Precision Medicine to Clinical Trial in a Dish


  • Human iPS Cells: From Precision Medicine to Clinical Trial in a Dish: Joseph C. Wu, Stanford, CA
  • Panel Q&A Discussion

Speaker(s): Moderator(s):
  • Gregg C. Fonarow, MD, FACC, FAHA, FHFSA, University of Los Angeles
  • JoAnn Lindenfeld, MD, Professor of Medicine Director, Advanced Heart Failure and Transplant, Vanderbilt Heart & Lung Institute

New Horizons in Nutrition in HF

Preview Available

New Horizons in Nutrition in HF


  • Dietary Intake of Foods High Inflammatory Content Associated with CRP and Event-Free Survival in Patients with HF: Sheryl Chow
  • Intersections Between Microbiome and HF: Revisiting the Gut Hypothesis : Justin Ezekowitz
  • Dietary Antioxidants and HF: Martha Biddle
  • Altered Metabolic Profile with Sodium-Restricted Dietary Approaches to Stop Hypertension Diet in Hypertensive HF with Preserved Ejection Fraction: Scott Hummel
  • Dietary Insufficiencies, Micro-nutrients, and Drug-Nutrient Interactions; Lorraine Evangelista
  • Panel Discussion

Moderator(s): Speaker(s):
  • Sheryl Chow, PharmD, FCCP, FAHA, FHFSA, BCPS, AQ-Cardiology, Associate Professor, Western University
  • Martha Biddle, PhD, APRN, CCNS, University of Kentucky
  • Scott Hummel, MD, MS, University of Michigan / Ann Arbor VA Health System
  • Lorraine Evangelista, PhD, RN, CNS, University of California, Irvine

Simplifying Hemodynamics with Complex Pressure Volume Loops

Preview Available

Simplifying Hemodynamics with Complex Pressure Volume Loops


  • Basics of Pressure Volume Loops
  • Case Presenter
  • Case Presenter
  • Panelist

Speaker(s):
  • Robb Kociol, MD, Director, Advanced Heart Failure and MCS, Beth Israel Deaconess Medical Center
  • Ryan Tedford, MD, Medical University of South Carolina
  • Arvind Bhimaraj, MD, MPH, FACC, FHFSA, Houston Methodist Hospital, Houston
  • James C. Fang, MD, FHFSA, Professor of Medicine; Chief, Division of Cardiovascular Medicine; Executive Director, Cardiovascular Service Line, University of Utah
  • Johnathan Rich, MD, FHFSA
  • Lynne Warner Stevenson, MD, Director of Cardiomyopathy, Lisa M Jacobson Professor of MedicineProfessor and Director of Cardiomyopathy & Program Director, Advanced Heart Failure Fellowship Program, Vanderbilt University

Transitioning Patients Out of the Hospital and Keeping Them Out (Joint Session with AAHFN)

Preview Available

Transitioning Patients Out of the Hospital and Keeping Them Out (Joint Session with AAHFN)


  • Adequate Hospital Management
  • Transition to Home
  • Transitions to Skilled Nursing Facilities
  • Keeping Patients Out of the Hospital
  • Managing Subacute Exacerbation
  • Panel Discussion

Moderator(s):
  • Linda Wick, MSN, Sr. Director of Ambulatory Nursing, M Health, Minneapolis, MN
  • Jo Ellen Rodgers, PharmD, BCPS, FCCP, FNAP, FAHA, FHFSA, Clinical Professor, University of North Carolina
Speaker(s):
  • Marie Galvao, MSN, ANP-BC, CHFN, Lead Heart Failure Nurse Practitioner, Center for Advanced Cardiac Therapy, Montefiore Medical Center
  • Linda Ordway, RN, MS, ACNP, CHFN, NP, Clinical Care Manager, Cardiomyopathy Center
  • Kismet Rasumusson
  • Lisa D. Rathman, MSN, CRNP, Lead Heart Failure Nurse Practitioner, Lancaster General Heart Failure Clinic
  • Sara Paul, DNP, FNP, FHFSA, Director, Heart Function Clinic, Catawba Valley Cardiology

Navigating the Slippery Slope of Advanced HFS:  A Look Beyond the Usual Suspects

Preview Available

Navigating the Slippery Slope of Advanced HFS: A Look Beyond the Usual Suspects


  • KEYNOTE: Cell Therapy to Prevent and Treat HF
  • Chronic Inotrope Therapy in End Stage HF: Better than an LVAD
  • Inotropes are no REMATCH for an LVAD!
  • One Size Does Not Fit All: What (and When) is the Best Treatment Option in the Acutely Decompensated HF Patient?
  • Acute HF: Phenotype and choice of vasoactive agent - Vasodilators or Inotropes
  • Beyond Drugs: ECMO, Impella, or Nothing? Timing and Exit Strategy
  • Chronic Aortic Counterpulsation: Kinder, Gentler Assist?
  • Panel Discussion

Moderator(s): Speaker(s):

The Prevention of HF (Joint Session with AHA)

Preview Available

The Prevention of HF (Joint Session with AHA)


  • The Definition of HF in Epidemiologic Studies: Are We Underestimating the Prevalence?
  • Hypertension and HF: Has SPRINT Taught Us Something New?
  • Diabetes and HF: Is There Hope in SGLT2 Inhibitors?
  • Panel Discussion Moderator
  • Can we Prevent HF Following Chemotherapy- Can We Predict It?
  • Now that HIV is a Chronic Disease – Is it Leading to HF?
  • Biomarkers Used to Predict and Prevent the Risk of HF
  • Panel Discussion

Moderator(s):
  • JoAnn Lindenfeld, MD, Professor of Medicine Director, Advanced Heart Failure and Transplant, Vanderbilt Heart & Lung Institute
Speaker(s):

The Systemic Effects of Continuous Flow Physiology

Preview Available

The Systemic Effects of Continuous Flow Physiology


  • Defining and Quantifying Pulsatility on Mechanical Circulatory Support
  • Alterations in Hemostatic Mechanisms w/ Continuous‐Flow: Bleeding & Thrombotic Implications
  • The Renal Response to Continuous Flow
  • The Effects of Continuous Flow on Exercise Physiology and Baroreceptor Sensitivity
  • Vascular Structure and Function in a Continuous‐Flow Environment
  • Panel Discussion

Moderator(s):
  • Cynthia Bither, ACNP, ANP, Chief NP, Advanced Heart Failure Program, Medstar Washington Hospital Center Washington, DC
  • Stuart D. Russell, MD, Duke University
Speaker(s):

FDA Special Session – Off-Label Drug Use

Preview Available

FDA Special Session – Off-Label Drug Use


  • Scope of the Issue
  • Compelling Cases
  • Risk vs Benefit
  • Who Should Educate?
  • Panel Discussion (30 min)

Moderator(s):
  • Mona Fiuzat, PharmD, Adjunct Associate Professor, Food and Drug Administration (FDA)/Duke University
  • Peter Pang, MD, Indiana University School of Medicine
Speaker(s):

Case Discussion - Clinical Conundrums

Preview Available

Case Discussion - Clinical Conundrums


  • Panelist - Cardiologist
  • Panelist - Nurse
  • Panelist - Pharmacist
  • Panelist - EP

Moderator(s):
  • Barry H. Greenberg, MD
  • James C. Fang, MD, FHFSA, Professor of Medicine; Chief, Division of Cardiovascular Medicine; Executive Director, Cardiovascular Service Line, University of Utah
Speaker(s):
  • Alan Miller, MD, University Florida HSC
  • Ileana Piña, MD, MPH, Professor of Medicine and Epidemiology/Population Health, Albert Einstein College of Medicine
  • JoAnn Lindenfeld, MD, Professor of Medicine Director, Advanced Heart Failure and Transplant, Vanderbilt Heart & Lung Institute
  • Sara Paul, DNP, FNP, FHFSA, Director, Heart Function Clinic, Catawba Valley Cardiology
  • Sana Al-Khatib, MD, MHS
Print Certificate
Review Answers
Print Transcript
Completed on: token-completed_on
Review Answers
Please select the appropriate credit type:
/
test_id: 
credits: 
completed on: 
rendered in: 
* - Indicates answer is required.
token-content

token-speaker-name
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
/
/
token-index
token-content
token-index
token-content